Literature DB >> 24085761

Subacute liver failure following anakinra treatment for adult-onset Still disease.

Lilian Aly1, Christof Iking-Konert, Alexander Quaas, Daniel Benten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085761     DOI: 10.3899/jrheum.121309

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Jaundice in a patient treated with Anakinra in a context of Covid-19.

Authors:  H Tarhini; M Husain; N Poey; S Lariven; F-X Lescure; Y Yazdanpanah; A Gervais
Journal:  Infect Dis Now       Date:  2020-09-30

Review 2.  Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review.

Authors:  Parth Shah; Vinay Sundaram; Einar Björnsson
Journal:  Hepatol Commun       Date:  2020-01-02

3.  Corticosteroid-Induced Liver Injury in Adult-Onset Still's Disease.

Authors:  Chin-Chi Lee; Yi-Jen Peng; Chun-Chi Lu; Hsiang-Cheng Chen; Fu-Chiang Yeh
Journal:  Medicina (Kaunas)       Date:  2022-01-27       Impact factor: 2.430

Review 4.  Biological therapy of traditional therapy-resistant adult-onset Still's disease: an evidence-based review.

Authors:  Sha Zhou; Jianjun Qiao; Juan Bai; Yinhua Wu; Hong Fang
Journal:  Ther Clin Risk Manag       Date:  2018-01-24       Impact factor: 2.423

5.  Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Authors:  Serena Colafrancesco; Maria Manara; Alessandra Bortoluzzi; Teodora Serban; Gerolamo Bianchi; Luca Cantarini; Francesco Ciccia; Lorenzo Dagna; Marcello Govoni; Carlomaurizio Montecucco; Roberta Priori; Angelo Ravelli; Paolo Sfriso; Luigi Sinigaglia
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.